Skip to search formSkip to main contentSkip to account menu

JM 118

Known as: JM-118, JM118 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study
AbstractHydration reactions of two anticancer Pt(IV) complexes JM149 and JM216 (Satraplatin) were studied computationally… 
2008
2008
COMPARATIVE PROTEIN BINDING, STABILITY AND DEGRADATION OF SATRAPLATIN, JM118 AND CISPLATIN IN HUMAN PLASMA IN VITRO
1 Satraplatin is an investigational orally administered platinum‐based antitumour drug. The present study compared the plasma… 
2008
2008
Preparation, characterization and in vitro anticancer activity of platinum(II) complexes with N-Cyclohexyl-1,3-propanediamine as the carrier.
New JM118 (active form of satraplatin) analogues with N-cyclohexyl-1,3-propanediamine (N-chpda) as the carrier, cis-[Pt(N-chpda… 
Highly Cited
2007
Highly Cited
2007
Preclinical antitumor activity of the oral platinum analog satraplatin
PurposeSatraplatin is an orally available platinum analog. The purpose of this study was to better characterize satraplatin’s… 
2007
2007
The polyamines spermidine and spermine retard the platination rate of single-stranded DNA oligomers and plasmids.
2006
2006
Satraplatin, an oral platinum analog, is active and synergistic with paclitaxel and docetaxel in prostate carcinoma models.
14620 Background: Satraplatin is a novel oral platinum analog with potent cytotoxic and antitumor activity in preclinical models… 
1996
1996
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Two pairs of cis/trans platinum complexes, JM118 (cis-ammine(cyclohexylamine) dichloro platinum(II)) and its trans counterpart… 
Highly Cited
1995
Highly Cited
1995
Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin…
The mechanisms by which cis-diamminedichloroplatinum(II) (cisplatin) is transported across the plasma membrane (i.e., passive… 
1995
1995
Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltrates.
1995
1995
Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)